Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation (Q38332737)

2 September 2017

title

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation (English)

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657399

transcriptional activation

22 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657399

22 October 2022

T. Crook

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657399

22 October 2022

J. A. Tidy

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657399

22 October 2022

K. H. Vousden

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1657399

22 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

2 September 2017

https://api.elsevier.com/content/article/PII:0092867491905298?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

https://api.elsevier.com/content/article/PII:0092867491905298?httpAccept=text/plain

22 October 2022

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

22 October 2022

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

547-556

1 reference

Suppression of human colorectal carcinoma cell growth by wild-type p53

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Degradation of nuclear oncoproteins by the ubiquitin system in vitro

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

p53 point mutation in HPV negative human cervical carcinoma cell lines

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The nucleotide sequence and genome organization of human papilloma virus type 11.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

p53 functions as a cell cycle control protein in osteosarcomas

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Presence of a potent transcription activating sequence in the p53 protein

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The p53 proto-oncogene can act as a suppressor of transformation

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Cyclin is degraded by the ubiquitin pathway

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Monoclonal antibodies specific for simian virus 40 tumor antigens

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

T antigen is bound to a host protein in SY40-transformed cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Primary structure polymorphism at amino acid residue 72 of human p53.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Comparison of the in vitro transforming activities of human papillomavirus types.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Human papillomavirus oncoproteins

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

Monoclonal antibody analysis of p53 expression in normal and transformed cells

22 October 2022

1 reference

https://api.crossref.org/works/10.1016/0092-8674(91)90529-8

22 October 2022

Identifiers

DOI

1 reference

2 September 2017

1 reference